Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma: Randomized Clinical Trial

NCT06761313 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT06761313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06761313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma: Randomized Clinical Trial
Lead sponsor
Federal University of São Paulo
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 1, 2021
Completion date
February 26, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, quality of life (qol)